Navigation Links
Anadys Pharmaceuticals to Present at the Citi Biotech Day
Date:3/25/2009

SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will present at Citi's 4th Annual Biotech Day on Wednesday, April 1, 2009 at 11:20 a.m. EDT (8:20 a.m. PDT). The conference will be held at the 388 Greenwich Street Conference Center in New York City.

Steve Worland, Ph.D., President and Chief Executive Officer of Anadys, will provide an overview of Anadys and an update on its ANA598 clinical program in hepatitis C.

The corporate presentation will be simultaneously webcast and can be accessed on the Investor Relations page of the Company's website at www.anadyspharma.com. Listeners are encouraged to visit the website approximately five minutes prior to the corporate presentation to download or install any necessary software. A replay of the presentation will be available approximately one hour after the live webcast concludes and will be available through April 15, 2009.

About Anadys

Anadys Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. For the treatment of chronic hepatitis C, the Company is developing two potentially complementary agents, ANA598, a non-nucleoside polymerase inhibitor and ANA773, an oral inducer of endogenous interferons that acts via the TLR7 pathway. The Company is also developing ANA773 for the treatment of cancer.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to Anadys' strategy, development programs, and ability to develop novel medicines in t
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Anadys Pharmaceuticals to Present at BIO InvestorForum 2007
2. Anadys Pharmaceuticals to Present at Bio Investor Forum
3. Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study
4. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
5. Anadys Pharmaceuticals to Report Fourth Quarter and Year End 2008 Financial Results
6. Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results and Highlights
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... (PRWEB) October 20, 2014 Women’s health ... in Obstetrics & Gynecology of Columbus, Inc., A Division ... healthcare services to more than 100,000 patients annually. Dr. ... all ages and stages of a women’s life. She ... locations in Westerville and Dublin. , Dr. Murphy ...
(Date:10/20/2014)... Kennewick, WA (PRWEB) October 20, 2014 ... new workflow management software application. The new module ... ensure patients receive full life-cycle quality care. , This ... to others within their practice, attach a to-do item ... see fit, and even set up reoccurring reminders for ...
(Date:10/20/2014)... 2014 Succeed is proud to announce that ... participated in the Every Body Walk! campaign by ... project that encourages workers to be more active outside of ... which concluded at the end of September, was a friendly ... metro areas. Participating companies gave their staff pedometers and ...
(Date:10/20/2014)... 2014 It’s hard to imagine what it’s ... vulnerable children around the world, it’s a reality. And while ... children are forced to walk barefoot on rocky terrain or ... play with their friends. , Buckner International's Shoes ... Radio in October to encourage support for Air1 and ...
(Date:10/19/2014)... 20, 2014 The leading review ... http://www.top10bestseohosting.com/go/iPage/ ) and GreenGeeks are the best Dedicated ... for those who want to buy high quality ... , The IT manager of Top10BestSEOHosting.com says, “We ... recommended suppliers for everyone. A lot of the ...
Breaking Medicine News(10 mins):Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 2Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 3Health News:My Clients Plus Announces New Workflow Management Software 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2
... Even when surgical tumor removal is combined with a heavy ... cancer will not return. Now researchers at Tel Aviv University ... and an immunity to the cancer,s return with ... "tumor ablation" a process through which the tumor is destroyed ...
... study into the ways lungs grow and develop has challenged ... the age of three. The researchers, led by a ... for the first time based on research evidence that new ... contradicts information in most medical textbooks that explain that the ...
... By Amanda Gardner HealthDay Reporter , MONDAY, Dec. 5 ... for his overall health than his body weight, a novel finding ... online Dec. 5 in the journal Circulation finds that ... live longer, regardless of whether your body weight has stayed the ...
... MONDAY, Dec. 5 (HealthDay News) -- Eating fish rich ... significantly lower a young woman,s risk of developing heart ... of childbearing age who never ate fish had 50 percent ... a 90 percent higher risk than women who ate fish ...
... PARK, Md. -- Social determinants, including the lack of paid ... influenza A (H1N1) virus among Hispanics in the U.S. during ... Sandra Crouse Quinn, professor of family science and senior associate ... University of Maryland School of Public Health. The findings are ...
... Dec. 5 (HealthDay News) -- Policies that dictate minimum requirements ... increased levels of physical activity among children, a new ... in school, which makes schools important locations for combating overweight ... Illinois at Chicago noted in the report, published online Dec. ...
Cached Medicine News:Health News:Blasting cancer from the inside out 2Health News:Blasting cancer from the inside out 3Health News:University of Leicester study fundamentally alters our understanding of lung growth 2Health News:Fitness May Lower Death Risk Even Without Weight Loss 2Health News:Fitness May Lower Death Risk Even Without Weight Loss 3Health News:Fish May Cut Threat of Heart Disease in Young Women 2Health News:Fish May Cut Threat of Heart Disease in Young Women 3Health News:Maryland study finds that US Hispanics were at greater risk for H1N1 flu during 2009 pandemic 2Health News:U.S. School Kids Often Miss Out on Recess, Study Finds 2
(Date:10/17/2014)... , October 17, 2014 ... ) has announced the addition of the  ... to their offering.       (Logo: ... disease in China ... changes in consumption concept, dietary habit, way ...
(Date:10/17/2014)... Investor-Edge has initiated coverage on the following ... NPS Pharmaceuticals Inc. (NASDAQ: NPSP ), XOMA ... (NASDAQ: MNTA ), and Catalyst Pharmaceutical Partners ... can be accessed at: http://investor-edge.com/register . ... on a mixed note as the Dow Jones Industrial ...
(Date:10/17/2014)... SM , the nation,s leader in medication monitoring solutions, ... M.D., as Chief Medical Officer. In this role, Smith ... healthcare providers, patients and managed care plans.   ... of healthcare companies that have provided him with experiences ... sides of Ameritox,s business. He most recently served as ...
Breaking Medicine Technology:China Interventional Cardiovascular Device Industry Report 2014-2017 2China Interventional Cardiovascular Device Industry Report 2014-2017 3Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 2Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 3Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 4Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 5Ameritox Appoints New Chief Medical Officer 2
... , PITTSBURGH , May 4 Mylan Inc. (Nasdaq: ... final approval from the U.S. Food and Drug Administration (FDA) for its ... 150 mg, the generic version of GlaxoSmithKline,s smoking cessation aid, Zyban®.   ... Bupropion HCl ER Tablets ...
... , May 3 Avantis ... catheter-mounted digital imaging devices, today announced five new studies ... colonoscopy procedures increases detection of adenomas and polyps.  The ... experience, were able to detect adenomas of all sizes ...
Cached Medicine Technology:Mylan Receives Approval for Generic Version of Zyban(R) 2Third Eye(R) Retroscope(R) Demonstrates Improved Adenoma Detection 2Third Eye(R) Retroscope(R) Demonstrates Improved Adenoma Detection 3Third Eye(R) Retroscope(R) Demonstrates Improved Adenoma Detection 4Third Eye(R) Retroscope(R) Demonstrates Improved Adenoma Detection 5Third Eye(R) Retroscope(R) Demonstrates Improved Adenoma Detection 6
Fine .12mm Tip With 5mm Platform; In Titanium....
45 Degree Angle With 0.3, 12 Teeth with 5mm Tying Platform; In Titanium....
Curved 30mm shaft (in stainless steel); rubber coated for safer use; includes 1.5 meter cable and connectors....
0.3mm tips; 9.5mm from tips to cross action; in Titanium....
Medicine Products: